EdgarLookup

SUTRO BIOPHARMA, INC. — All Filings

593 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 3/A 4 4/A 424B4 424B5 8-A12B 8-K ARS CERT CORRESP CT ORDER D D/A DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT POS AM POS EX POSASR PRE 14A REGDEX REGDEX/A S-1 S-1/A S-1MEF S-3 S-3ASR S-3MEF S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 FORM 4 SUBMISSION 0001209191-23-040213 Jun 29, 2023 Jun 27, 2023
8-K 8-K 0000950170-23-029731 Jun 26, 2023 Jun 21, 2023
8-K 8-K 0000950170-23-027975 Jun 14, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036479 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036473 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036466 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036467 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036474 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036470 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036471 Jun 12, 2023 Jun 8, 2023
4 FORM 4 SUBMISSION 0001209191-23-036472 Jun 12, 2023 Jun 8, 2023
8-K 8-K 0000950170-23-021973 May 15, 2023
10-Q 10-Q 0000950170-23-021976 May 15, 2023 Mar 31, 2023
3 FORM 3 SUBMISSION 0001209191-23-026700 May 2, 2023 May 1, 2023
4 FORM 4 SUBMISSION 0001209191-23-026736 May 2, 2023 May 1, 2023
ARS ARS 0001140361-23-021534 Apr 28, 2023 Dec 31, 2022
DEFA14A DEFA14A 0000950170-23-015774 Apr 28, 2023
DEF 14A DEF 14A 0000950170-23-015762 Apr 28, 2023 Jun 8, 2023
8-K 8-K 0000950170-23-015323 Apr 27, 2023 Apr 24, 2023
4 FORM 4 SUBMISSION 0001209191-23-024550 Apr 17, 2023 Apr 14, 2023
PRE 14A PRE 14A 0000950170-23-012876 Apr 14, 2023 Jun 8, 2023
8-K 8-K 0000950170-23-012879 Apr 14, 2023 Apr 10, 2023
8-K 8-K 0000950170-23-010978 Mar 30, 2023
10-K 10-K 0000950170-23-010976 Mar 30, 2023 Dec 31, 2022
4 FORM 4 SUBMISSION 0001209191-23-019599 Mar 17, 2023 Mar 15, 2023
4 FORM 4 SUBMISSION 0001209191-23-016818 Mar 7, 2023 Mar 3, 2023
3 FORM 3 SUBMISSION 0001209191-23-016804 Mar 7, 2023 Mar 1, 2023
4 FORM 4 SUBMISSION 0001209191-23-016736 Mar 7, 2023 Mar 3, 2023
4 FORM 4 SUBMISSION 0001209191-23-016739 Mar 7, 2023 Mar 3, 2023
3 FORM 3 SUBMISSION 0001209191-23-016798 Mar 7, 2023 Feb 28, 2023
4 FORM 4 SUBMISSION 0001209191-23-016742 Mar 7, 2023 Mar 3, 2023
4 FORM 4 SUBMISSION 0001209191-23-016747 Mar 7, 2023 Mar 3, 2023
4 FORM 4 SUBMISSION 0001209191-23-016751 Mar 7, 2023 Mar 3, 2023
4 FORM 4 SUBMISSION 0001209191-23-016794 Mar 7, 2023 Mar 3, 2023
4 FORM 4 SUBMISSION 0001209191-23-016809 Mar 7, 2023 Mar 3, 2023
S-8 S-8 0000950170-23-004676 Feb 27, 2023
8-K 8-K 0000950170-23-004373 Feb 24, 2023
SC 13G/A SC 13G/A 0001580642-23-000874 Feb 14, 2023
4 FORM 4 SUBMISSION 0001209191-23-009236 Feb 14, 2023 Feb 13, 2023
SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000524 Feb 14, 2023
SC 13G/A 0000919574-23-000973 Feb 13, 2023
SC 13G SC 13G 0001104659-23-018473 Feb 10, 2023
SC 13G/A 0001306550-23-008351 Feb 7, 2023
4 FORM 4 SUBMISSION 0001209191-23-005757 Jan 31, 2023 Jan 27, 2023
4 FORM 4 SUBMISSION 0001209191-23-005759 Jan 31, 2023 Jan 27, 2023
4 FORM 4 SUBMISSION 0001209191-23-005762 Jan 31, 2023 Jan 27, 2023
4 FORM 4 SUBMISSION 0001209191-23-005751 Jan 31, 2023 Jan 27, 2023
4 FORM 4 SUBMISSION 0001209191-23-005754 Jan 31, 2023 Jan 27, 2023
4 FORM 4 SUBMISSION 0001209191-23-005765 Jan 31, 2023 Jan 27, 2023
SC 13G/A 0001273087-23-000051 Jan 23, 2023